Gapping down
In reaction to disappointing earnings/guidance: ILMN -18.3%, RMBS -13.8%, NFLX -8.7%, LECO -5.3%, EAT -4.5%, IBM-4.1%, CMA -3%, PM -2.8%, BRO -1.4%, GS -1.1%
Other news: CPST -22.3% (to offer common stock and warrants), SUNE -6.5% (Greenlight Capital/David Einhorn disclosed reduced stake in SUNE), AMDA -4% (modestly pulling back following yday's strength), SCMP -2% (announces top-line data from a Phase 2a study of cobiprostone; did not meet its primary endpoints and co intends to discontinue development for PPI-refractory NERD/sGERD), RAI -0.8% (in sympathy with PM)
Analyst comments: EBAY -2.8% (downgraded to Underweight from Equal-Weight at Morgan Stanley), ADTN -1.7% (downgraded to Sell from Neutral at Goldman), AMAT -1.2% (downgraded to Negative from Neutral at Susquehanna), AMT -0.9% (downgraded to Hold from Buy at Evercore ISI)
In reaction to disappointing earnings/guidance: ILMN -18.3%, RMBS -13.8%, NFLX -8.7%, LECO -5.3%, EAT -4.5%, IBM-4.1%, CMA -3%, PM -2.8%, BRO -1.4%, GS -1.1%
Other news: CPST -22.3% (to offer common stock and warrants), SUNE -6.5% (Greenlight Capital/David Einhorn disclosed reduced stake in SUNE), AMDA -4% (modestly pulling back following yday's strength), SCMP -2% (announces top-line data from a Phase 2a study of cobiprostone; did not meet its primary endpoints and co intends to discontinue development for PPI-refractory NERD/sGERD), RAI -0.8% (in sympathy with PM)
Analyst comments: EBAY -2.8% (downgraded to Underweight from Equal-Weight at Morgan Stanley), ADTN -1.7% (downgraded to Sell from Neutral at Goldman), AMAT -1.2% (downgraded to Negative from Neutral at Susquehanna), AMT -0.9% (downgraded to Hold from Buy at Evercore ISI)